NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live iBio, Inc. Common Stock Share Price Chart

O H L

iBio, Inc. Common Stock Performance Overview

Days Range
$1.25Low
$1.27High

Markets Today

Previous Close$1.25
Open$1.27
Volume90,580
Day's Range$1.25 - $1.27
52W RangeNA
Market Cap$75.88 M

Historical Performance

1M Returns-13.79
3M Returns-26.04
6M Returns-42.92
1Y Returns+43.68
5Y Returns-99.80
10Y Returns-99.96

iBio, Inc. Common Stock Fundamentals

Market Cap$75.88 M
Dividend yieldN/A
PE RatioN/A
PEG RatioN/A
Revenue$100.00 K
ROE TTMN/A
EPS TTMN/A
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-29.56 M
Profit Margin-33044.00
Market Cap$75.88 M
Dividend yieldN/A
PE RatioN/A
PEG RatioN/A
Revenue$100.00 K
ROE TTMN/A
EPS TTMN/A
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-29.56 M
Profit Margin-33044.00

iBio, Inc. Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$200.00 K$100.00 K$0$0$0
Gross Profit +$0$200.00 K$100.00 K$0$0$0
Operating Income -$4.88 M-$5.20 M-$5.95 M$0-$8.37 M-$11.38 M
EBITDA -$4.75 M-$5.07 M-$5.82 M$0-$8.21 M-$6.22 M
Interest Expense -$54.00 K-$44.00 K-$36.00 K$0-$22.00 K$46.00 K
Depreciation $126.00 K$126.00 K$128.00 K$0$152.00 K$5.16 M
Income Before Tax -$4.86 M-$5.16 M-$5.72 M$0-$7.76 M-$10.58 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$4.86 M-$5.16 M-$5.72 M$0-$7.76 M-$10.58 M
Net Profit Margin --2581.5%-5720%---

iBio, Inc. Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $10.00 K$19.00 K$20.00 K$30.00 K$35.00 K$56.00 K
Reserve & Surplus -$327.06 M-$332.22 M-$337.96 M-$346.93 M-$354.69 M-$365.31 M
Non-Current Liabilities $2.33 M$2.20 M$2.07 M$1.93 M$1.79 M$1.65 M
Current Liabilities $5.40 M$6.11 M$6.05 M$5.90 M$6.50 M$11.74 M
Total Liabilities $7.72 M$8.30 M$8.12 M$7.83 M$8.30 M$13.40 M
Fixed Assets $9.39 M$10.01 M$10.05 M$7.79 M$5.14 M$4.91 M
Current Assets $6.06 M$9.72 M$50.77 M$53.37 M$77.25 M$92.22 M
Total Assets $19.10 M$23.18 M$64.16 M$64.39 M$85.83 M$99.11 M

iBio, Inc. Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$4.86 M-$5.16 M-$5.72 M-$8.99 M-$7.73 M-$10.60 M
Operating Cash Flow -$3.10 M-$4.62 M-$5.67 M-$5.24 M-$6.10 M-$6.21 M
Investing Cash Flow -$14.00 K$45.00 K-$21.49 M-$2.98 M-$3.11 M-$4.41 M
Financing Cash Flow $1.06 M$8.18 M$46.70 M$8.79 M$28.15 M$19.40 M
Change in Cash -$2.06 M$3.61 M$19.55 M$561.00 K$18.96 M$8.76 M

iBio, Inc. Common Stock Return Calculator

The iBio, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$20
Invested Amount$10,000
Est. Returns$-9,980
Invest in USA Stock Today

About iBio, Inc. Common Stock

iBio Inc is a clinical-stage biotechnology company using Artificial Intelligence (AI) for the development of hard-to-drug precision antibodies for obesity, cardiometabolic, and cardiopulmonary diseases. Its product candidate pipeline includes IBIO-610, a monoclonal antibody designed to block Activin E; IBIO-800, a bispecific antibody program targeting myostatin, growth differentiation factor 11 (GDF11), and Activin A; IBIO-600; Amylin Antibody; and Target 4, in different stages of development, being developed as potential therapies for obesity and cardiometabolic disease. The company operates as one reportable segment, which is that of a biotechnology company leveraging AI and ML for the development of hard-to-drug precision antibodies.

FAQs

iBio, Inc. Common Stock (IBIO) share price as of September 18, 2026 is $1.26. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the iBio, Inc. Common Stock (IBIO) Share by opening an international trading account with Angel One.
Purchasing iBio, Inc. Common Stock (IBIO) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying iBio, Inc. Common Stock (IBIO) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of iBio, Inc. Common Stock (IBIO) or any other US company shares in Angel One for any dollar amount.
The market capitalization of iBio, Inc. Common Stock on September 18, 2026, is $75.88 M.
iBio, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in iBio, Inc. Common Stock (IBIO) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91